Shared Decision Making Working Group

What is shared decision making?

What are shared decision making outcomes?

About

Shared decision making (SDM) is central to patient-centered care and is at the crossroads between evidence-based medicine and patient-centered care. In the last decade, there has been increasing interest in SDM in rheumatology and an imperative to use SDM to achieve optimal care.
The use of consensus-building methods following the OMERACT Filter 2.1 methodology, grounded in a patient-oriented approach, led to strong endorsement of a core domain set for SDM interventions in rheumatology trials.
Future research will include the development of a core outcome measurement set to identify instruments to assess these domains in trials of SDM interventions.
The OMERACT SDM WG is classified as a ‘bolton’ group. ‘Bolt-on groups’ describe the additional domains and instruments that are part of a specific intervention, and which are measured in addition to disease-specific core outcome sets. In a clinical trial of SDM interventions, the trial must measure both the core outcome set specific to the concept of SDM and include the disease-specific core outcome set of the clinical trial’s study population. By doing so, we ensure that we measure both intervention-specific and disease-specific outcomes.

Current Stage in the OMERACT Process

The team is conducting a Delphi study and systematic review to select instruments that capture how patients and clinicians make treatment decisions together. Findings will guide future trial reporting.

Latest Update

Current Objectives and Focus Areas
The group is preparing to systematically search for development and validation studies of a few selected candidate instruments that are the most used in research. Additionally, we will conduct a Delphi study to assess domain match and feasibility. This will be an important step in selecting instruments to assess SDM core domains.
Recent Milestones Achieved
Reached consensus on SDM domain definitions and descriptions
Completed scoping review identifying a long list of candidate instruments
Upcoming Activities and Deliverables
In the coming months, the SDM working group will continue developing our core set through structured calls and iterative feedback. As a team, we will agree on a protocol for the next steps and will conduct a literature search, as well as a Delphi study. We will then submit results for publication. As we look ahead to OMERACT 2027, we will focus on preparing for key discussions and presentations to ensure meaningful contributions to the broader OMERACT community.
Additional Information
The group is exploring the best approach to conduct this work and to secure funding to support the next phases of this work.

Next Meeting

TBD
IS Roadmap (1)

Meet the Team

Karine Toupin April

Karine Toupin April, Canada
Chair

Jennifer Barton

Jennifer Barton, USA
Chair

Simon Décary

Simon Décary, Canada
Chair

Liana Fraenkel

Liana Fraenkel, USA
Chair

Linda Li

Linda Li, Canada
Chair

Florian-Naye

Florian Naye, Canada
OMERACT Fellow

OMERACT Endorsed Bolt On for Clinical Trials of SDM interventions

SDM endorsed bolt on
Untitled design (2)

Recent Publications

  1. Naye, Florian, et al. “OMERACT Core Outcome Measurement Set for Shared Decision Making in Rheumatic and Musculoskeletal Conditions: A Scoping Review to Identify Candidate Instruments.” Seminars in Arthritis and Rheumatism, vol. 65, 152344, 2024, https://doi.org/10.1016/j.semarthrit.2023.152344.
  2. Décary, Simon, et al. “Consensus on the Definitions and Descriptions of the Domains of the OMERACT Core Outcome Set for Shared Decision Making Interventions in Rheumatology Trials.Seminars in Arthritis and Rheumatism, vol. 65, 152381, 2024, https://doi.org/10.1016/j.semarthrit.2024.152381.
  3. Toupin-April, Karine, et al. “Endorsement of the OMERACT Core Domain Set for Shared Decision Making Interventions in Rheumatology Trials: Results from a Multi-Stepped Consensus-Building Approach.Seminars in Arthritis and Rheumatism, vol. 51, no. 3, 2021, pp. 593–600, https://doi.org/10.1016/j.semarthrit.2021.03.017.

  4. April, Karine Toupin, et al. “Development of a Core Domain Set of Outcomes for Shared Decision Making Interventions: An OMERACT White Paper with Stakeholders’ Input.Journal of Rheumatology, vol. 46, no. 10, 2019, pp. 1409–14, https://doi.org/10.3899/jrheum.181071.

  5. Toupin-April, Karine, et al. “Toward the Development of a Core Set of Outcome Domains to Assess Shared Decision-Making Interventions in Rheumatology: Results from an OMERACT Delphi Survey and Consensus Meeting.Journal of Rheumatology, vol. 44, no. 10, 2017, pp. 1544–50, https://doi.org/10.3899/jrheum.161241.

  6. Toupin-April, Karine, et al. “Development of a Draft Core Set of Domains for Measuring Shared Decision Making in Osteoarthritis: An OMERACT Working Group on Shared Decision Making.” Journal of Rheumatology, vol. 42, no. 12, 2015, pp. 2442–47, https://doi.org/10.3899/jrheum.141205.
 
 
 
 

New to OMERACT?

OMERACT Working Groups follow a structured, consensus-driven approach to developing Core Outcome Sets. Explore how this process unfolds and discover more about how OMERACT advances outcome measurement in rheumatology.
Scroll to Top